Back to search

Article

A Phase I, single and continuous administration study of Safety, tolerability and pharmacokinetics of neorudin, a noval recombinant anticoagulant protein, in healthy subjects

2024-01-30

Abstract excerpt

AIMS: The aims of the study were to evaluate the tolerability, safety and pharmacokinetics of single and continuous administration of recombinant neorudin (EPR-hirudin, EH) by intravenous injection in healthy subjects, and to provide a safe dosage range for phase II clinical research. METHODS: A single and continuous administration dose phase I clinical study was conducted. Forty-four subjects were received EH as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ee29f139-d659-553f-87db-4435cc782ee8
DOI
10.22541/au.170664618.84732094/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 11 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Phase I, single and continuous administration study of Safety, tolerability and pharmacokinetics of neorudin, a noval recombinant anticoagulant protein, in healthy subjectsDOI 10.22541/au.170664618.84732094/v1
Select a neighboring publication to make it the new centre.